Cure8 research brief
The paper suggests that loss of microbial bile acid transformations in IBD reduces activation of the TGR5 receptor, and that lower TGR5 bioactivity correlates with higher inflammatory activity — a potential mechanism linking microbiome changes to IBD inflammation.
Researchers (microbiome, bile-acid metabolism, immune pathways), clinicians following biomarker research in IBD, and adult patients interested in microbiome-driven mechanisms of disease activity.
The authors measured bile acids in stool and blood, used those profiles to estimate TGR5 receptor activation, and performed metagenomic sequencing on the same fecal samples.
They found lower microbial diversity in IBD, reduced capacity for converting primary to secondary bile acids, a lower secondary-to-primary bile acid ratio, and lower predicted TGR5 bioactivity in patients versus controls.
The results are associative: the paper reports correlations between bile acid composition, predicted TGR5 activation, and markers of inflammatory activity rather than demonstrating a proven causal treatment effect. This work points to bile acid–microbiome–receptor pathways as promising targets for future research and potential therapies.
Findings are associative from biochemical profiling and metagenomics reported in the article abstract; they highlight pathways for further study but do not establish causation or treatment effects.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: Universitätsklinikum Jena
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The review highlights how microbial metabolites, epigenetic regulation, and mitochondrial metabolism interact to shape inflammation and barrier function in IBD. Understanding these links could help identify new...
The study suggests a plant-derived AHR-activating mechanism that reduced inflammation and repaired the intestinal barrier in preclinical ulcerative colitis models, a pathway that could be relevant to future therapies or...
Researchers are exploring whether gut microbes differ in patients who develop fibrous strictures — a common, surgery-prone complication of Crohn’s disease — because that could help predict risk or point to new prevention...
